BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Brune A, Metze D, Luger TA, Ständer S. [Antipruritic therapy with the oral opioid receptor antagonist naltrexone. Open, non-placebo controlled administration in 133 patients]. Hautarzt 2004;55:1130-6. [PMID: 15517116 DOI: 10.1007/s00105-004-0802-8] [Cited by in Crossref: 35] [Cited by in F6Publishing: 27] [Article Influence: 2.1] [Reference Citation Analysis]
Number Citing Articles
1 Raap U, Ikoma A, Kapp A. Neurophysiologie des Pruritus. Hautarzt 2006;57:379-84. [DOI: 10.1007/s00105-006-1125-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
2 Grundmann SA, Ständer S. Evaluation of chronic pruritus in older patients. Aging Health 2010;6:53-66. [DOI: 10.2217/ahe.09.84] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
3 Cassano N, Tessari G, Vena GA, Girolomoni G. Chronic pruritus in the absence of specific skin disease: an update on pathophysiology, diagnosis, and therapy. Am J Clin Dermatol 2010;11:399-411. [PMID: 20866115 DOI: 10.2165/11317620-000000000-00000] [Cited by in Crossref: 27] [Cited by in F6Publishing: 19] [Article Influence: 2.5] [Reference Citation Analysis]
4 Reszke R, Szepietowski JC. Can we use psychoactive drugs to treat pruritus? Exp Dermatol 2019;28:1422-31. [PMID: 31087719 DOI: 10.1111/exd.13959] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
5 Lewis D, Huang S, Duvic M. Inflammatory cytokines and peripheral mediators in the pathophysiology of pruritus in cutaneous T-cell lymphoma. J Eur Acad Dermatol Venereol 2018;32:1652-6. [DOI: 10.1111/jdv.15075] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
6 Wang Z, Jiang C, Yao H, Chen O, Rahman S, Gu Y, Zhao J, Huh Y, Ji R. Central opioid receptors mediate morphine-induced itch and chronic itch via disinhibition. Brain 2021;144:665-81. [DOI: 10.1093/brain/awaa430] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
7 Malekzad F, Arbabi M, Mohtasham N, Toosi P, Jaberian M, Mohajer M, Mohammadi M, Roodsari M, Nasiri S. Efficacy of oral naltrexone on pruritus in atopic eczema: a double-blind, placebo-controlled study. Journal of the European Academy of Dermatology and Venereology 2009;23:948-50. [DOI: 10.1111/j.1468-3083.2009.03129.x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 26] [Article Influence: 2.5] [Reference Citation Analysis]
8 Reszke R, Krajewski P, Szepietowski JC. Emerging Therapeutic Options for Chronic Pruritus. Am J Clin Dermatol 2020;21:601-18. [PMID: 32607945 DOI: 10.1007/s40257-020-00534-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
9 Bin Saif GA, Ericson ME, Yosipovitch G. The itchy scalp--scratching for an explanation. Exp Dermatol 2011;20:959-68. [PMID: 22092575 DOI: 10.1111/j.1600-0625.2011.01389.x] [Cited by in Crossref: 37] [Cited by in F6Publishing: 31] [Article Influence: 3.7] [Reference Citation Analysis]
10 Mansour-Ghanaei F, Taheri A, Froutan H, Ghofrani H, Nasiri-Toosi M, Bagherzadeh AH, Farahvash MJ, Mirmomen S, Ebrahimi-Dariani N, Farhangi E, Pourrasouli Z. Effect of oral naltrexone on pruritus in cholestatic patients. World J Gastroenterol 2006; 12(7): 1125-1128 [PMID: 16534857 DOI: 10.3748/wjg.v12.i7.1125] [Cited by in CrossRef: 49] [Cited by in F6Publishing: 37] [Article Influence: 3.1] [Reference Citation Analysis]
11 Yamamoto A, Kuyama S, Kamei C, Sugimoto Y. Characterization of scratching behavior induced by intradermal administration of morphine and fentanyl in mice. European Journal of Pharmacology 2010;627:162-6. [DOI: 10.1016/j.ejphar.2009.10.066] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.2] [Reference Citation Analysis]
12 Ständer S. [Rational symptomatic therapy for chronic pruritus]. Hautarzt 2006;57:403-10. [PMID: 16583225 DOI: 10.1007/s00105-006-1123-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
13 Buddenkotte J, Steinhoff M. Pathophysiology and therapy of pruritus in allergic and atopic diseases. Allergy 2010;65:805-21. [PMID: 20384615 DOI: 10.1111/j.1398-9995.2010.01995.x] [Cited by in Crossref: 83] [Cited by in F6Publishing: 61] [Article Influence: 6.9] [Reference Citation Analysis]
14 Metz M, Grundmann S, Ständer S. Pruritus: an overview of current concepts. Vet Dermatol 2011;22:121-31. [PMID: 21251097 DOI: 10.1111/j.1365-3164.2010.00945.x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 22] [Article Influence: 2.6] [Reference Citation Analysis]
15 Zeidler C, Pfleiderer B, Ständer S. Neues zur Therapie des chronischen Pruritus. Hautarzt 2016;67:627-34. [DOI: 10.1007/s00105-016-3828-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
16 Phan NQ, Bernhard JD, Luger TA, Ständer S. Antipruritic treatment with systemic μ-opioid receptor antagonists: a review. J Am Acad Dermatol. 2010;63:680-688. [PMID: 20462660 DOI: 10.1016/j.jaad.2009.08.052] [Cited by in Crossref: 109] [Cited by in F6Publishing: 77] [Article Influence: 9.1] [Reference Citation Analysis]
17 Ständer S, Weisshaar E, Luger TA. Neurophysiological and neurochemical basis of modern pruritus treatment. Exp Dermatol 2008;17:161-9. [PMID: 18070080 DOI: 10.1111/j.1600-0625.2007.00664.x] [Cited by in Crossref: 62] [Cited by in F6Publishing: 53] [Article Influence: 4.1] [Reference Citation Analysis]
18 Ständer S, Pereira MP, Berger T, Zeidler C, Augustin M, Bobko S, Brenaut E, Chen SC, Chisolm S, Dalgard FJ, Elberling J, Elmariah SB, Evers AW, Garcovich S, Gonçalo M, Halvorsen JA, Kim BS, Kupfer J, Lambert J, Legat FJ, Lerner EA, Leslie TA, Lönndahl L, Lvov A, Metz M, Misery L, Papadavid E, Potekaev NN, Reich A, Savk E, Schneider G, Schut C, Serra-baldrich E, Ständer HF, Streit M, Szepietowski JC, Tharp MD, Wallengren J, Nast A, Weisshaar E, Yosipovitch G. IFSI-guideline on chronic prurigo including prurigo nodularis. Itch 2020;5:e42-e42. [DOI: 10.1097/itx.0000000000000042] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
19 Sikora M, Rakowska A, Olszewska M, Rudnicka L. The Use of Naltrexone in Dermatology. Current Evidence and Future Directions. Curr Drug Targets 2019;20:1058-67. [PMID: 30887922 DOI: 10.2174/1389450120666190318121122] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
20 Metz M, Wahn U, Gieler U, Stock P, Schmitt J, Blume-peytavi U. Chronic pruritus associated with dermatologic disease in infancy and childhood: Update from an interdisciplinary group of dermatologists and pediatricians. Pediatr Allergy Immunol 2013;24:527-39. [DOI: 10.1111/pai.12115] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
21 Guo J, Ba X, Matsuda M, Wei P, Jiang C, Sun W, Xiao L, Xiong D, Liao X, Hao Y. Oxytocin Elicits Itch Scratching Behavior via Spinal GRP/GRPR System. Front Neurosci 2020;14:581977. [PMID: 33071749 DOI: 10.3389/fnins.2020.581977] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
22 Pereira MP, Nau T, Zeidler C, Ständer S. [Chronic prurigo]. Hautarzt 2018;69:321-30. [PMID: 29568995 DOI: 10.1007/s00105-018-4145-2] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
23 Fostini AC, Girolomoni G, Tessari G. Prurigo nodularis: an update on etiopathogenesis and therapy. J Dermatolog Treat 2013;24:458-62. [PMID: 23767411 DOI: 10.3109/09546634.2013.814759] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 3.7] [Reference Citation Analysis]
24 Serrano L, Martinez-escala ME, Zhou XA, Guitart J. Pruritus in Cutaneous T-Cell Lymphoma and Its Management. Dermatologic Clinics 2018;36:245-58. [DOI: 10.1016/j.det.2018.02.011] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
25 Steinhoff M, Cevikbas F, Ikoma A, Berger TG. Pruritus: management algorithms and experimental therapies. Semin Cutan Med Surg 2011;30:127-37. [PMID: 21767775 DOI: 10.1016/j.sder.2011.05.001] [Cited by in Crossref: 40] [Cited by in F6Publishing: 27] [Article Influence: 3.6] [Reference Citation Analysis]
26 Zeidler C, Pereira M, Ständer S. The Neuromodulatory Effect of Antipruritic Treatment of Chronic Prurigo. Dermatol Ther (Heidelb) 2019;9:613-22. [PMID: 31512177 DOI: 10.1007/s13555-019-00321-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]